ZC3H4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.994400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.488800E-01
Normal-vs-Stage2
3.038400E-01
Normal-vs-Stage3
5.186400E-02
Normal-vs-Stage4
3.629400E-01
Stage1-vs-Stage2
7.225000E-01
Stage1-vs-Stage3
2.494400E-02
Stage1-vs-Stage4
8.926400E-01
Stage2-vs-Stage3
3.089500E-02
Stage2-vs-Stage4
6.321800E-01
Stage3-vs-Stage4
1.723160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.959200E-01
Normal-vs-AfricanAmerican
2.137200E-01
Normal-vs-Asian
7.264200E-02
Caucasian-vs-AfricanAmerican
5.144200E-01
Caucasian-vs-Asian
8.398000E-01
AfricanAmerican-vs-Asian
5.615800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.234170E-02
Normal-vs-Female
2.901400E-01
Male-vs-Female
6.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.072600E-01
Normal-vs-Age(41-60Yrs)
3.249200E-01
Normal-vs-Age(61-80Yrs)
1.301760E-02
Normal-vs-Age(81-100Yrs)
2.565000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.414600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.947400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.748200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.214600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.037600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.923000E-03
Normal-vs-Daily Drinker
2.161500E-02
Normal-vs-Weekly Drinker
1.166550E-01
Normal-vs-Occasional Drinker
5.881800E-02
Normal-vs-Social Drinker
3.645000E-01
Non Drinker-vs-Daily Drinker
7.024000E-01
Non Drinker-vs-Weekly Drinker
2.402800E-01
Non Drinker-vs-Occasional Drinker
1.760010E-01
Non Drinker-vs-Social Drinker
9.969800E-02
Daily Drinker-vs-Weekly Drinker
4.248200E-01
Daily Drinker-vs-Occasional Drinker
3.570600E-01
Daily Drinker-vs-Social Drinker
2.250200E-01
Weekly Drinker-vs-Occasional Drinker
9.907400E-01
Weekly Drinker-vs-Social Drinker
8.174800E-01
Occasional Drinker-vs-Social Drinker
7.727600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.720190E-01
Normal-vs-Grade 2
6.230600E-01
Normal-vs-Grade 3
5.799400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.748600E-01
Grade 1-vs-Grade 3
8.135200E-01
Grade 1-vs-Grade 4
1.720190E-01
Grade 2-vs-Grade 3
3.069400E-01
Grade 2-vs-Grade 4
6.230600E-01
Grade 3-vs-Grade 4
5.799400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.181890E-02
Normal-vs-NonDiabetic
3.014800E-01
Diabetic-vs-NonDiabetic
2.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.867800E-02
Normal-vs-NoPancreatitis
2.965400E-01
Pancreatitis-vs-NoPancreatitis
3.931200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.550050E-02
Normal-vs-N1
2.972000E-01
N0-vs-N1
8.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.162200E-01
Normal-vs-TP53-NonMutant
4.165400E-01
TP53-Mutant-vs-TP53-NonMutant
9.955800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
